Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT07520214
EARLY_PHASE1

Clinical Study on the Safety and Immunogenicity of Specific Cancer Vaccines in Preventing Recurrence of Glioblastoma

Sponsor: Beijing Neurosurgical Institute

View on ClinicalTrials.gov

Summary

This study evaluates the safety and specific antitumor immune responses of mRNA vaccines GV-108 and GV-907 in IDH-wildtype glioblastoma patients.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

9

Start Date

2025-09-10

Completion Date

2027-12-31

Last Updated

2026-04-09

Healthy Volunteers

No

Interventions

BIOLOGICAL

mRNA vaccine: GV-907、GV-108

Eligible patients will receive intradermal injections of cancer vaccines

Locations (1)

Beijing Tiantan Hospital

Beijing, Beijing Municipality, China